骶管注射联合穴位埋线治疗痔术后疼痛的观察

:-
 
摘要 目的:针对混合痔日间手术后静脉镇痛泵无法带回家的临床困境,探索骶管内注射长效镇痛药联合长强、承山穴位埋线作为替代镇痛方案的有效性与安全性。 方法:回顾性纳入2023年6月至2025年9月行混合痔外剥内扎术的患者60例,根据术后镇痛方案分为两组:治疗组(骶管注射+穴位埋线,30例)和对照组(静脉镇痛泵,30例)。比较两组术后2、8、24、48 h的疼痛视觉模拟评分(VAS)及不良反应。 结果:治疗组术后2 h、8 h、24 h的VAS评分均显著低于对照组(均P<0.05);48 h两组差异无统计学意义。治疗组尿失禁、尿潴留、排便困难各1例,对照组恶心呕吐4例、嗜睡5例、尿潴留4例,组间差异无统计学意义。 结论:骶管注射联合穴位埋线可有效缓解混合痔日间术后早期疼痛,避免了静脉镇痛泵无法家庭使用的限制,为日间手术提供了一种可行的镇痛替代方案。
Abstract Objective:To address the clinical challenge that intravenous patient-controlled analgesia (PCA) pumps cannot be taken home after ambulatory surgery for mixed hemorrhoids, and to evaluate the efficacy and safety of intrasacral canal injection of a long-acting analgesic combined with acupoint catgut embedding at Changqiang (GV1) and Chengshan (BL57) as an alternative analgesic regimen. Methods:A retrospective cohort study was conducted. Sixty patients who underwent Milligan-Morgan hemorrhoidectomy for mixed hemorrhoids between June 2023 and September 2025 were enrolled and divided into two groups according to the postoperative analgesic regimen: a treatment group (intrasacral injection + catgut embedding, n=30) and a control group (intravenous PCA pump, n=30). Pain intensity assessed by Visual Analogue Scale (VAS) and adverse reactions were compared between the two groups at 2, 8, 24, and 48 hours postoperatively. Results:The VAS scores in the treatment group were significantly lower than those in the control group at 2, 8, and 24 hours after surgery (all P < 0.05). No significant difference was observed at 48 hours. One case each of urinary incontinence, urinary retention and defecation difficulty occurred in the treatment group, while the control group had 4 cases of nausea/vomiting, 5 of drowsiness, and 4 of urinary retention, with no statistically significant differences between groups. Conclusion:Intrasacral canal injection combined with acupoint catgut embedding can effectively relieve early postoperative pain in ambulatory surgery for mixed hemorrhoids, circumventing the limitation that intravenous PCA pumps cannot be used at home, thus providing a feasible alternative analgesic strategy for ambulatory surgery.
临床诊疗

定经汤加减联合穴位埋线治疗多囊卵巢综合征不孕的临床研究

:113-115
 
目的 探究多囊卵巢综合征不孕患者采用定经汤加减联合穴位埋线治疗的临床价值。方法 研究对象为我院2020年3月—2021年3月收治的90例多囊卵巢综合征不孕患者,并采取随机抽签法分为对照组和研究组,对照组枸橼酸氯米芬胶囊治疗,研究组采用定经汤加减联合穴位埋线法治疗。对比2组患者治疗效果。结果 对比2组患者激素水平,干预前,对照组患者睾酮素(T)、黄体生成激素(LH)、卵泡生成激素(FSH)水平与研究组差异不具有统计学意义(P>0.05);干预后,研究组在改善FSH、LH、T水平方面优于对照组(P<0.05);干预前,2组患者中医症状积分对比差异不具有统计学意义(P>0.05);干预后,研究组患者中医证候分析较对照组改善(P<0.05);对照组患者子宫内膜厚度、排卵率及妊娠率均低于研究组患者(P<0.05)。结论 定经汤加减联合穴位埋线能够有效改善多囊卵巢综合征不孕患者性激素水平,促进排卵、提高临床妊娠率,具备临床应用价值。
出版者信息








《广州医药》公众号